← Open Payments lookup

JAIMY THOMAS: Open Payments

NPI 1215483490 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,579 in 84 payments from 20 companies in 2025. Trend: 2023 $1,173 · 2024 $1,736 · 2025 $1,579

Food & beverage: $1,579
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP16$299
ABBVIE INC.12$219
Amgen Inc.13$168
PFIZER INC.7$142
Novo Nordisk Inc5$106
Novartis Pharmaceuticals Corporation4$101
Boehringer Ingelheim Pharmaceuticals, Inc.5$98
Insmed, Inc.3$71
Axsome Therapeutics, Inc.3$64
GlaxoSmithKline, LLC.2$53

Products named: AIRSUPRA, OTEZLA, FARXIGA, LEQVIO, JARDIANCE, QULIPTA, ELIQUIS, Arikayce.

Industry payments across TX — which companies pay providers there.